Francesca T, Jinyao Z, Yun L. Longer dialysis session length is associated with better intermediate outcomes and survival among patients on in-center three times per week hemodialysis: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS) [J]. Nephrol Dial Transplant, 2012, 27(11):4180-4188.
[1]
Francesca T, Jinyao Z, Yun L. Longer dialysis session length is associated with better intermediate outcomes and survival among patients on in-center three times per week hemodialysis: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS) [J]. Nephrol Dial Transplant, 2012, 27(11):4180-4188.
[2]
Marilia S, Robin H, Silvia S, et al. Survival of hemodialysis patients: modeling differences in risk of dialysis centers[J]. Int J Qual Health Care, 2003, 15(5):189-196.
[2]
Marilia S, Robin H, Silvia S, et al. Survival of hemodialysis patients: modeling differences in risk of dialysis centers[J]. Int J Qual Health Care, 2003, 15(5):189-196.
[3]
Brian B, Jiaqi Q, Shuchi A, et al. Two-times weekly hemodialysis in China: frequency, associated patient and treatment characteristics and quality of life in the China dialysis outcomes and practice patterns study[J]. Nephrol Dial Transplant, 2013, 10(12):1093-1094.
[3]
Brian B, Jiaqi Q, Shuchi A, et al. Two-times weekly hemodialysis in China: frequency, associated patient and treatment characteristics and quality of life in the China dialysis outcomes and practice patterns study[J]. Nephrol Dial Transplant, 2013, 10(12):1093-1094.
[4]
Christos A, Chung C, Laura P, et al. Considerations in the Statistical Analysis of Hemodialysis Patient Survival[J]. J Am Soc Nephrol, 2009, 20(9):2034-2043.
[5]
Eduardo L, Jiang lin Xu, Rita S. Suri. Survival with Three-Times Weekly In-Center Nocturnal Versus Conventional Hemodialysis[J]. J Am Soc Nephrol, 2012, 23(4):687-695.
[4]
Christos A, Chung C, Laura P, et al. Considerations in the Statistical Analysis of Hemodialysis Patient Survival[J]. J Am Soc Nephrol, 2009, 20(9):2034-2043.
[6]
Ryota M, Atsuhiko M, Guoqin W. Habitual Physical Activity Measured by Accelerometer and Survival in Maintenance Hemodialysis Patients[J]. Clin J Am Soc Nephrol, 2012, 7(12):2010-2016.
[5]
Eduardo L, Jiang lin Xu, Rita S. Suri. Survival with Three-Times Weekly In-Center Nocturnal Versus Conventional Hemodialysis[J]. J Am Soc Nephrol, 2012, 23(4):687-695.
[6]
Ryota M, Atsuhiko M, Guoqin W. Habitual Physical Activity Measured by Accelerometer and Survival in Maintenance Hemodialysis Patients[J]. Clin J Am Soc Nephrol, 2012, 7(12):2010-2016.
[7]
Janus N, Launay V V, Deray G, et al. Management of targeted therapies in hemodialysis patients[J]. Bull Cancer, 2012, 99(3):381-388.
Marijke Korteweg. General Concepts with Regard to Quality Control/Quality Assurance in Data Management[J]. Drug Information J, 1993, 27(10):963-968.
[10]
Marijke Korteweg. General Concepts with Regard to Quality Control/Quality Assurance in Data Management[J]. Drug Information J, 1993, 27(10):963-968.
[11]
Mary K B, Sylvain P, Connie S, et al. Using a FOCUS-PDCA quality improvement model for applying the severe traumatic brain injury guidelines to practice: process and outcomes[J]. Based Nurs, 2003, 6(1):6-7.
[11]
Mary K B, Sylvain P, Connie S, et al. Using a FOCUS-PDCA quality improvement model for applying the severe traumatic brain injury guidelines to practice: process and outcomes[J]. Based Nurs, 2003, 6(1):6-7.
[12]
Renee G, Alan K, Beth S. Patient and Facility Safety in Hemodialysis: Opportunities and Strategies to Develop a Culture of Safety[J]. Clin J Am Soc Nephrol, 2012, 7(4):680-688.
[12]
Renee G, Alan K, Beth S. Patient and Facility Safety in Hemodialysis: Opportunities and Strategies to Develop a Culture of Safety[J]. Clin J Am Soc Nephrol, 2012, 7(4):680-688.
[13]
Marcello T, Natasha W, Bruce C, et al. Systematic review of the clinical efficacy and safety of sevelamer in dialysis patients[J]. Nephrol Dial Transplant, 2007, 22(10):2856-2866.
[14]
Ingrid L. On-line Preparation of Solutions for Dialysis: Practical Aspects Versus Safety and Regulations[J]. J Am Soc Nephrol, 2002, 13(1):78-83.
[13]
Marcello T, Natasha W, Bruce C, et al. Systematic review of the clinical efficacy and safety of sevelamer in dialysis patients[J]. Nephrol Dial Transplant, 2007, 22(10):2856-2866.
[15]
Carlo D, Angeliki K, Adoración M G. Extracorporeal dialysis: techniques and adequacy[J]. Nephrol Dial Transplant, 2012, 27(5):197-226.
[14]
Ingrid L. On-line Preparation of Solutions for Dialysis: Practical Aspects Versus Safety and Regulations[J]. J Am Soc Nephrol, 2002, 13(1):78-83.
[16]
Brad C A, Joseph A E, Neil R P. Type of Vascular Access and Survival among Incident Hemodialysis Patients: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study[J]. J Am Soc Nephrol, 2005, 16(5):1449-1455.
[15]
Carlo D, Angeliki K, Adoración M G. Extracorporeal dialysis: techniques and adequacy[J]. Nephrol Dial Transplant, 2012, 27(5):197-226.
[16]
Brad C A, Joseph A E, Neil R P. Type of Vascular Access and Survival among Incident Hemodialysis Patients: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study[J]. J Am Soc Nephrol, 2005, 16(5):1449-1455.
2015, Vol. 26 
